edoc

Items where Author is "Neervannan, Sesha"

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Date | Item Type | Refereed
Jump to: 2017 | 2016 | 2015
Number of items: 3.

2017

Hussaarts, Leonie and Mühlebach, Stefan and Shah, Vinod P. and McNeil, Scott and Borchard, Gerrit and Flühmann, Beat and Weinstein, Vera and Neervannan, Sesha and Griffiths, Elwyn and Jiang, Wenlei and Wolff-Holz, Elena and Crommelin, Daan J. A. and de Vlieger, Jon S. B.. (2017) Equivalence of complex drug products: advances in and challenges for current regulatory frameworks. Annals of the New York Academy of Sciences, 1407 (1). pp. 39-49.

2016

de Vlieger , Jon S. B. and Borchard, Gerrit and Shah, Vinod P. and Flühmann, Beat and Neervannan, Sesha and Mühlebach , Stefan F.. (2016) Is the EU ready for non-biological complex drug products? Generics and biosimilars initiative journal, 5 (3). pp. 101-102.

2015

Mühlebach , Stefan F. and Shah, Vinod P. and McNeil, Scott E. and Borchard, Gerrit and Weinstein, Vera and de Vlieger , Jon S. B. and Flühmann, Beat and Crommelin, Daan J. A. and Neervannan, Sesha. (2015) NBCDS and their follow-on versions: time for an editorial section (perspective). Generics and Biosimilars Initiative Journal, 4 (4). pp. 167-170.

This list was generated on Thu May 9 16:51:13 2024 CEST.